Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2012
08/01/2012CN102614496A Wood frog bone high-calcium tablets and preparation method thereof
08/01/2012CN102614464A Traditional Chinese medicine composition for treating diabetic foot
08/01/2012CN102614425A Medicinal liquor for preventing and controlling cardio-cerebrovascular disease
08/01/2012CN102614405A Traditional Chinese medicine decoction for curing limb pain caused by diabetic neuropathy
08/01/2012CN102614404A Health product with auxiliary effect on reducing blood glucose and preparation method thereof
08/01/2012CN102614401A Chinese medicinal compound potentilla chinensis powder or particle preparation for conditioning and treating emaciation-thirst disease
08/01/2012CN102614381A Blood vessel softening medicine wine and preparation method thereof
08/01/2012CN102614378A Yin nourishing and blood sugar lowering Chinese medicinal composition and preparation method as well as detection method thereof
08/01/2012CN102614374A Chinese medicine tablet with immunoregulation and hypoglycemic effects and preparation method thereof
08/01/2012CN102614359A Chinese medicinal preparation for treating diabetes and preparation method thereof
08/01/2012CN102614328A Traditional Chinese medicine for treating diabetic peripheral neuropathy
08/01/2012CN102614327A Medicine for treating hyperglycemia
08/01/2012CN102614314A Traditional Chinese medicine for treating diabetic heart disease
08/01/2012CN102614297A Chinese medicine for treating diabetic cutaneous pruritus
08/01/2012CN102614280A Chinese medicinal composition with blood fat reducing effect, and preparation method and application thereof
08/01/2012CN102614279A Chinese medicine for treating diabetic hypertension
08/01/2012CN102614276A Dahurian rose fruit leaf general flavone extract, and extracting method and medical application thereof
08/01/2012CN102614274A Traditional Chinese medicine for treating diabetic constipation
08/01/2012CN102614271A Chinese medicine for treating diabetic dyslipidemia
08/01/2012CN102614267A Chinese medicinal composition for treating diabetic nephropathy and preparation method thereof
08/01/2012CN102614266A Drug for treating hypertension and hyperlipidemia
08/01/2012CN102614258A Chinese medicinal composition with blood sugar reducing effect, and preparation method and application thereof
08/01/2012CN102614247A Application of red bean (bean, winged bean) extracts in preparing anti-diabetes medicines
08/01/2012CN102614240A Extract containing breviscapine and preparation method thereof
08/01/2012CN102614232A Acer truncatum health-care lozenge and preparation method thereof
08/01/2012CN102614231A Method for preparing cynomorium songaricum terpene and cynomorium songaricum polysaccharose from cynomorium songaricum
08/01/2012CN102614227A Ganoderma pill and processing method thereof
08/01/2012CN102614221A Novel liquid calcium
08/01/2012CN102614218A Crystal unit prepared through healing stone fusion and fusion method thereof
08/01/2012CN102614203A Xylo-oligosaccharide composition with effect of inhibiting alpha-glucosaccharase as well as application of xylo-oligosaccharide composition
08/01/2012CN102614202A Mixture and liquid medicine or oral liquid for injection
08/01/2012CN102614172A Application of T-type calcium channel retardant in drug for treating diabetes
08/01/2012CN102614143A High-stability vitamin C tablet and preparing process thereof
08/01/2012CN102614135A Cytidine disodium triphosphate suspension powder injection and preparation method thereof
08/01/2012CN102614127A Resveratrol nanoscale dispersoid and preparation method thereof
08/01/2012CN102614121A Silibinin injection composition and preparation process
08/01/2012CN102613549A Diet therapy product capable of regulating blood sugar and preparation method thereof
08/01/2012CN102613546A Diet therapy product capable of regulating blood fat and preparation method thereof
08/01/2012CN102613456A Xylo-oligosaccharide composition with lipase activity inhibition effect and application of xylo-oligosaccharide composition
08/01/2012CN102613455A Xylo-oligosaccharide composition with cholesterol esterase activity inhibition function and application thereof
08/01/2012CN102613453A Marine organism type enteral nutrition preparation for diabetes patients, preparation method of marine organism type enteral nutrition preparation and application
08/01/2012CN102613356A Aquilaria agallocha leaf tea, as well as preparation and application thereof
08/01/2012CN102266359B Method for continuously extracting hypoglycemic active ingredient and estrogen active ingredient from tamariskoid spikemoss herbs
08/01/2012CN101797270B Silkworm pupal oil fat emulsion intravenous fluid and preparation method
08/01/2012CN101198319B Granular preparation containing biguanide compound
07/2012
07/31/2012US8232383 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
07/31/2012US8232291 Heterocyclic aromatic compounds useful as growth hormone secretagogues
07/31/2012US8232260 In vivo production of small interfering RNAs that mediate gene silencing
07/31/2012US8232258 NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and variants thereof, and their use
07/31/2012US8231910 Combining EDTA-sodium-metal complex(es) and the sodium selenite solution to from trace element soultuton to provide the solution to the animals
07/31/2012US8231897 Hydrostatic delivery system for controlled delivery of agent
07/31/2012US8231873 Methods of treatment using antibodies to Neutrokine-alpha
07/31/2012CA2703688C Use of bile acid or bile salt fatty acid conjugates
07/31/2012CA2528323C 2-hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide
07/31/2012CA2528322C 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl) piperidine as glucosylceramide synthase (gcs)
07/31/2012CA2515505C Inhibitor for perioperative blood sugar elevation
07/31/2012CA2458471C Prostaglandin analogs as chloride channel opener
07/31/2012CA2370948C Growth factor homolog zvegf4
07/26/2012WO2012100208A1 Modified release compositions of epalrestat or a derivative thereof and methods for using the same
07/26/2012WO2012100010A1 Apolipoprotein aiv as an antidiabetic peptide
07/26/2012WO2012099999A2 Methods and compositions for inducing weight loss
07/26/2012WO2012099851A2 Prenatal enzyme replacement therapy
07/26/2012WO2012099381A2 Preparation method of intermediate of sitagliptin
07/26/2012WO2012099139A1 FERRIC CITRATE CONTAINING SUBSTANTIALLY NO β-OXIDIZED IRON HYDROXIDE
07/26/2012WO2012098537A1 Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
07/26/2012WO2012098462A1 Combination of acylated glucagon analogues with insulin analogues
07/26/2012WO2012098400A1 Piperazine derivatives as cav2.2 calcium channel blockers
07/26/2012WO2012098387A1 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
07/26/2012WO2012098217A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders
07/26/2012WO2012098213A1 Fused aminodihydrothiazine derivatives useful as bace inhibitors
07/26/2012WO2012098064A1 1,4 oxazines as bace1 and/or bace2 inhibitors
07/26/2012WO2012097744A1 Mineralocorticoid receptor antagonists
07/26/2012WO2012097429A1 Probiotic soft gel compositions
07/26/2012WO2012097428A1 Compounds and pharmaceutical compositions for uses in diabetes
07/26/2012WO2012034039A3 Anti-il-1 beta antibodies and methods of use
07/26/2012WO2012033353A3 Sesterterpene compounds and use thereof
07/26/2012WO2011154711A8 Peptide-carrying nanoparticles
07/26/2012WO2011083150A3 Obesity small molecules
07/26/2012US20120190747 Method of treatment using fatty acid synthesis inhibitors
07/26/2012US20120190743 Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity
07/26/2012US20120190725 Inhibitor(s) of transporters or uptake of monoaminergic neurotransmitters
07/26/2012US20120190716 Methods and uses of cytochrome p450 inhibitors
07/26/2012US20120190699 Pyridones useful as inhibitors of kinases
07/26/2012US20120190696 Inhibitors of fatty acid binding protein (fabp)
07/26/2012US20120190690 Eltoprazine for the treatment of weight disorders
07/26/2012US20120190689 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist
07/26/2012US20120190677 Novel tetrahydroquinoline derivatives
07/26/2012US20120190675 Azaspirohexanones
07/26/2012US20120190672 Fused aminodihydrothiazine derivatives
07/26/2012US20120190658 Method And Composition For The Treatment Of Adverse Skin Conditions
07/26/2012US20120190656 Methods for selecting therapies to improve hdl cholesterol and triglyceride levels
07/26/2012US20120190654 Novel bicyclic urea compounds
07/26/2012US20120190649 Bicyclic aryl sphingosine 1-phosphate analogs
07/26/2012US20120190643 Carbohydrate composition for flat glucose response
07/26/2012US20120190640 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
07/26/2012US20120190634 Lipoteichoic acid-derived glycolipids, and compositions comprising same
07/26/2012US20120190618 Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes
07/26/2012US20120190616 Analogues of Insulin-Like Growth Factor-1 (IGF-1) Having Amino Acid Substitution at Position 59
07/26/2012US20120190615 Methods and compositions for inducing weight loss
07/26/2012US20120189724 Polyphenol-containing composition for oral administration or external use and use of same
1 ... 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 ... 1298